Abstract
Serum cholesterol precursor sterols reflect the activity of cholesterol synthesis. In this study, squalene, methyl sterol and lathosterol contents were studied in very low density lipoprotein (VLDL), low density lipoprotein (LDL) and high density lipoprotein (HDL) of heterozygous familial hypercholesterolemia patients without and with ileal bypass. The contents of lathosterol and all methyl sterols (lanosterol, Δ8,24-dimethylsterol, Δ8-dimetylsterol, Δ8-methostenol and methostenol), but not of squalene were increased in all lipoproteins by ileal bypass. The increase in the free methyl sterols was more marked than that in the esterified ones. The percentage esterification of the methyl sterols was highest in HDL and lowest in VLDL. Lipoprotein methyl sterol contents were positively correlated with each other and with cholesterol synthesis. The methyl sterols were slightly concentrated in LDL, and squalene strongly concentrated in VLDL. It is concluded that long-term stimulation of cholesterol synthesis increases the methyl sterols in all lipoproteins.
Similar content being viewed by others
Abbreviations
- Cholesterol:
-
cholest-5-en-3β-ol
- Δ8-dimethylsterol (4,4-dimethyl-5α-cholest-8-en-3β-ol):
-
4,4-dimethyl-5α-cholest-8-en-3β-ol
- Δ8,24-dimethylsterol (4,4-dimethyl-5α-cholest-8(7),24-dien-3β-ol):
-
4,4-dimethyl-5α-cholest-8(7), 24-dien-3β-ol
- HDL:
-
high density lipoprotein
- HMG-CoA:
-
hydroxymethylglutaryl coenzyme A
- lanosterol:
-
4,4,14α-trimethyl-5α-cholest-8,24-dien-3β-ol
- lathosterol:
-
5α-cholest-7-en-3β-ol
- LDL:
-
low density lipoprotein
- methostenol:
-
4α-methyl-5α-cholest-7-en-3β-ol
- Δ8-methostenol (4α-methyl-5α-cholest-8-en-3β-ol):
-
4α-methyl-5α-cholest-8-en-3β-ol
- VLDL:
-
very low density lipoprotein
- GLC:
-
gas liquid chromatography
- TLC:
-
thin layer chromatography
References
Miettinen, T.A. (1969)Life Sci. 8, 713–721.
Miettinen, T.A. (1970)Ann. Clin. Res. 2, 300–320.
Björkhem, J., Miettinen, T., Reihner, E., Ewerth, S., Angelin, B., and Einarsson, K. (1987)J. Lipid Res. 28, 1137–1143.
Vuoristo, M., and Miettinen, T.A. (1986)Gut 27, 1312–1319.
Färkkilä, M.A., Tilvis, R.S., and Miettinen, T.A. (1988)Gut 29, 188–195.
Miettinen, T.A. (1982)J. Lipid Res. 23, 466–473.
Miettinen, T.A. (1988)J. Lipid Res. 29, 43–51.
Miettinen, T.A. (1971)Ann. Clin. Res. 3, 264–271.
Miettinen, T.A. (1971)Eur. J. Clin. Invest. 1, 452–460.
Miettinen, T.A., and Koivisto, P. (1983) inBile Acids and Cholesterol in Health and Disease (Paumgartner, G., Stiehl, A., and Gerok, W., eds.) pp. 183–187, MTP Press, Lancaster, England.
Miettinen, T.A. (1985)Metabolism 34, 425–430.
Buchwald, H., and Varco, R.L. (1966)J. Am. Med. Assoc. 196, 627–630.
Ahlström, A., Räsänen, L., and Kuvaja, K. (1972)Ann. Acad. Sci. Fenn., A IV Biol. 194, 1–8.
White, E.C., McNamara, D.J., and Ahrens, E.H. Jr. (1981)Am. J. Clin. Nutr. 34, 199–203.
Grundy, S.M., Ahrens, E.H. Jr., and Miettinen, T.A. (1965)J. Lipid Res. 6, 397–410.
Miettinen, T.A., Ahrens, E.H. Jr., and Grundy, S.M. (1965)J. Lipid Res. 6, 411–424.
Havel, R.J., Eder, H.A., and Bragdon, J.H. (1955)J. Clin. Invest. 34, 1345–1353.
Lipid Research Clinics Program (1974)Manual of Laboratory Operations Vol. 1, pp. 51–59, DHEW Publication No. (NIH) 75-628, Bethesda, MD.
Kessler, G., and Lederer, H. (1966) inAutomation in Analytical Chemistry (Skeggs, L.T., ed.) pp. 341–344, Medical Inc., New York, NY.
Liu, G.C.K., Ahrens, E.H. Jr., Schreibman, P.H., and Crouse, J.R. (1976)J. Lipid Res. 17, 38–45.
Saudek, C.D., Frier, B.M., and Liu, G.C.K. (1978)J. Lipid Res. 19, 827–835.
Tilvis, R.S., and Miettinen, T.A. (1980)Scand. J. Clin. Lab. Invest. 40, 671–674.
Author information
Authors and Affiliations
About this article
Cite this article
Koivisto, P.V.I., Miettinen, T.A. Increased amounts of cholesterol precursors in lipoproteins after ileal exclusion. Lipids 23, 993–996 (1988). https://doi.org/10.1007/BF02536349
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02536349